Patient Clinical Trials

Clinical Trials: Pernicious Anemia

San Diego , California

Open-label, Single Agent, Phase 3 Clinical Study to Evaluate the Efficacy of Cobacan™ for the treatment of pernicious anemia.

Status

Recruiting

Purpose

The purpose of this study is to evaluate the effectiveness of Cobacan™.

This is a Phase 3 clinical study.

Trial Criteria

Minimum Age: 18 years

Genders eligible for study: Both

Call Now To Volunteer

•  866-5-BEBAAS
(1-866-523-2227)

 

Clinical Trials: Cancer

An Open-Label Clinical Trial Evaluating the Safety and Pharmacodynamics of Cbl-NO30™ in Subjects with Chronic Myelogenous Leukemia

Safety Evaluation of Cbl-NO30 in Chronic Myelogenous Leukemia

Status

Not yet recruiting

Purpose

To determine the dose and schedule of Cbl-NO30™ in adult subjects with chronic stage CML.

This is a Phase 1 clinical study.